UA100376C2 - Therapeutic agent for glaucoma containing adenosine derivative as active ingredient - Google Patents

Therapeutic agent for glaucoma containing adenosine derivative as active ingredient

Info

Publication number
UA100376C2
UA100376C2 UAA200911727A UAA200911727A UA100376C2 UA 100376 C2 UA100376 C2 UA 100376C2 UA A200911727 A UAA200911727 A UA A200911727A UA A200911727 A UAA200911727 A UA A200911727A UA 100376 C2 UA100376 C2 UA 100376C2
Authority
UA
Ukraine
Prior art keywords
group
therapeutic agent
cycloalkyl
glaucoma
hydrogen atom
Prior art date
Application number
UAA200911727A
Other languages
English (en)
Ukrainian (uk)
Inventor
Atsushi Shimazaki
Noriko Kawabata
Tomoko Kirihara
Jayson M Rieger
Robert D Thompson
Original Assignee
Santen Pharmaceutical Co Ltd
Pgxhealth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Pgxhealth Llc filed Critical Santen Pharmaceutical Co Ltd
Publication of UA100376C2 publication Critical patent/UA100376C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
UAA200911727A 2007-04-16 2008-04-14 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient UA100376C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007106915A JP2008266143A (ja) 2007-04-16 2007-04-16 アデノシン誘導体を有効成分として含有する緑内障治療剤

Publications (1)

Publication Number Publication Date
UA100376C2 true UA100376C2 (en) 2012-12-25

Family

ID=39875791

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200911727A UA100376C2 (en) 2007-04-16 2008-04-14 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient

Country Status (15)

Country Link
US (2) US20100093770A1 (ru)
EP (1) EP2134174A4 (ru)
JP (2) JP2008266143A (ru)
KR (1) KR20090128495A (ru)
CN (1) CN101677544A (ru)
AU (1) AU2008241496A1 (ru)
BR (1) BRPI0809953A2 (ru)
CA (1) CA2684866A1 (ru)
EA (1) EA015971B1 (ru)
IL (1) IL201418A0 (ru)
MX (1) MX2009011076A (ru)
NZ (1) NZ580165A (ru)
UA (1) UA100376C2 (ru)
WO (1) WO2008130520A1 (ru)
ZA (1) ZA200906989B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985754B2 (en) * 2006-07-17 2011-07-26 Trovis Pharmaceuticals, Llc Selective antagonists of A2A adenosine receptors
CN102711771B (zh) 2010-01-11 2016-05-18 伊诺泰克制药公司 降低眼压的组合、试剂盒和方法
KR20130029049A (ko) * 2010-03-26 2013-03-21 이노텍 파마슈티컬스 코포레이션 아데노신 화합물 및 이의 용도
CN102933593A (zh) 2010-03-26 2013-02-13 伊诺泰克制药公司 使用n6-环戊基腺苷（cpa）、cpa衍生物或其前药降低人眼内压的方法
US20120058983A1 (en) 2010-09-02 2012-03-08 Bayer Pharma Aktiengesellschaft Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
JP2012180346A (ja) * 2011-02-10 2012-09-20 Santen Pharmaceut Co Ltd 親水性薬物の薬物移行性を改善した水性組成物
EA027109B1 (ru) 2012-01-26 2017-06-30 Инотек Фармасьютикалс Корпорейшн Безводные полиморфы [(2r,3s,4r,5r)-5-(6-(циклопентиламино)-9h-пурин-9-ил)-3,4-дигидрокситетрагидрофуран-2-ил]метилнитрата и способы их получения
MX2015013234A (es) 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.
WO2017137528A1 (en) 2016-02-12 2017-08-17 Charité - Universitätsmedizin Berlin Adenosine a1 receptor agonist for use in treatment of status epilepticus
KR102007640B1 (ko) 2017-11-29 2019-08-07 퓨쳐메디신 주식회사 아데노신 유도체를 포함하는 망막 질환 또는 시신경 질환 예방 및 치료용 약학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6322771B1 (en) * 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
CA2460911C (en) * 2001-10-01 2011-08-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
EP2335734A3 (en) * 2003-09-12 2012-01-11 Allergan, Inc. Treatment of pain and other alpha 2 adrenergic-mediated conditions
US7605143B2 (en) * 2004-08-02 2009-10-20 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity
US7368439B2 (en) * 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
JP2008285478A (ja) * 2007-04-16 2008-11-27 Santen Pharmaceut Co Ltd アデノシンａ２ａ受容体アゴニストを有効成分として含有する緑内障治療剤

Also Published As

Publication number Publication date
WO2008130520A1 (en) 2008-10-30
CA2684866A1 (en) 2008-10-30
EA200901402A1 (ru) 2010-04-30
MX2009011076A (es) 2010-01-20
EP2134174A4 (en) 2011-05-25
US20100093770A1 (en) 2010-04-15
IL201418A0 (en) 2010-06-16
CN101677544A (zh) 2010-03-24
US20130109646A1 (en) 2013-05-02
BRPI0809953A2 (pt) 2014-09-23
ZA200906989B (en) 2010-06-30
JP2008266143A (ja) 2008-11-06
JP4923141B2 (ja) 2012-04-25
EA015971B1 (ru) 2012-01-30
KR20090128495A (ko) 2009-12-15
AU2008241496A1 (en) 2008-10-30
JP2010524933A (ja) 2010-07-22
NZ580165A (en) 2012-07-27
EP2134174A1 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
UA100376C2 (en) Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
WO2008087933A1 (ja) ＩκＢキナーゼβ阻害活性を有する新規インドール誘導体
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
RS54047B1 (en) PROCEDURE FOR OBTAINING 4-OXOCHINOLINE COMPOUNDS
MY142768A (en) Gfat inhibitors
EP1845081A4 (en) amide
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
TW200637539A (en) CTGF inhibitors
TW200606152A (en) Piperidine compound and process for preparing the same
AU2006325931A8 (en) Amine compound and use thereof for medical purposes
TW200726470A (en) 6,7-unsaturated-7-carbamoylmorphinan derivatives
WO2009047298A3 (en) Dimers of harmol or of its derivatives and uses thereof
MX2010006882A (es) Derivado novedoso de catecol, composición farmaceutica que contiene el mismo, uso del derivado de catecol, y uso de la composición farmaceutica.
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
EA201170595A1 (ru) ПРОИЗВОДНОЕ ФЕНАНТРОИНДОЛИЗИДИНА И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ АКТИВНОГО ИНГРЕДИЕНТА
SG170049A1 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
MX2010001566A (es) Derivado de aminopirazolamida.
WO2009001784A1 (ja) Ｎ-フェニル－メタナミン誘導体及びこれを含有する有害生物防除剤
EA201170596A1 (ru) ФЕНАНТРОИНДОЛИЗИДИНОВОЕ СОЕДИНЕНИЕ И ИНГИБИТОР NFkB, СОДЕРЖАЩИЙ ЕГО В КАЧЕСТВЕ ДЕЙСТВУЮЩЕГО ИНГРЕДИЕНТА
WO2009063897A1 (ja) 皮膚の乾癬予防または改善剤
MX2007002531A (es) Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos.
TW200734336A (en) 6-Heteroarylpyridoindolone derivatives, preparation thereof and therapeutic use thereof
MY146775A (en) Amino alcohol derivative and immunosuppressive agent having same as an active ingredient